Command Palette

Search for a command to run...

NATHBIOGEN

152.332.89 (1.93%)

Quarterly ResultsProfit & LossBalance SheetCash Flow

Key Insights

POSITIVE
  • Recent quarter shows a significant improvement in net profit compared to lower prior quarters.
  • Despite increased expenditures, the previous quarter had positive operating margins indicating operational efficiency.
  • Latest net sales peaked significantly compared to previous quarters, reflecting strong market demand.
NEGATIVE
  • Company experienced a cash flow shortfall with a 10% decrease this year [Dummy Data]
  • Company’s strategic partnerships have yet to generate expected growth. [Dummy Data]
  • Company’s EBITDA shrank at a CAGR of -8% over the past 3 years. [Dummy Data]
Quarterly Results Data
FieldTrendMar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25
Revenue
43.04243.8832.1936.8751.97283.7043.8565.96
Expenses
41.16210.4131.1833.5654.26249.5942.3967.90
Operating Profit
1.8733.471.013.31-2.2934.111.46-1.94
Other Income
0.410.130.080.483.861.761.941.74
Interest
1.072.242.983.901.373.203.664.54
Depreciation
0.980.820.820.821.340.970.990.97
Profit Before Tax
2.2933.601.093.791.5735.883.392.48
Tax
0.610.25-0.031.140.630.660.640.87
Net Profit
2.6233.361.112.651.4837.282.751.60
EPS in Rs
1.8717.490.531.331.1419.581.400.84